GE to phase out lab rats, use embryonic stem cells for testing instead
July 02, 2009
General Electric has announced plans to phase out the use of laboratory rats in the testing of drug safety, and use embryonic stem cells in their place. In explaining the move, a company spokesman said that the use of human tissues would be more efficient in measuring the effects of drugs. While acknowledging the "considerable debate" about the use of human embryos, a GE statement concluded: "We conduct our research in an ethically and scientifically responsible manner."
For all current news, visit our News home page.
Further information:
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
